Journal
CLINICAL CASE REPORTS
Volume 9, Issue 8, Pages -Publisher
WILEY
DOI: 10.1002/ccr3.4604
Keywords
antiangiogenic treatment; glioblastoma multiforme; pseudoresponse; RANO criteria; regorafenib; tyrosine kinase inhibitors
Categories
Ask authors/readers for more resources
Treatment with antiangiogenic agents in glioblastoma can lead to a distinct MRI pattern, characterized by decreased contrast enhancement on T1-weighted images and simultaneous hyperintensity on T2-weighted or fluid-attenuated inversion recovery images.
Antiangiogenic agents can induce a distinct MRI pattern in glioblastoma, characterized by a decrease in the contrast enhancement on T1-weighted images and a simultaneous hyperintensity on T2-weighted or fluid-attenuated inversion recovery images.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
